T. Rowe Price Investment Management, Inc. 13D and 13G filings for Immunocore Holdings plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:06 am Sale | 2026-03-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 1,891,600 3.700% | -1,150,304 (-37.82%) | Filing |
| 2026-03-06 12:57 pm Sale | 2026-02-28 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 3,041,904 6.000% | -2,919,323 (-48.97%) | Filing |
| 2026-02-17 10:28 am Sale | 2025-12-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 5,961,227 11.800% | -1,090,591 (-15.47%) | Filing |
| 2025-05-14 10:47 am Purchase | 2025-03-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 7,051,818 14.100% | 551,983 (+8.49%) | Filing |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 6,499,835 13.000% | 1,334,936 (+25.85%) | Filing |
| 2024-09-10 1:49 pm Purchase | 2024-08-31 | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | T. Rowe Price Investment Management, Inc. | 5,164,899 10.300% | 5,164,899 (New Position) | Filing |